Intellectual Property Law and Copyright Laws

On July 10, Apple filed a complaint in the U.S. District Court for the Northern District of California asserting claims under the federal Defend Trade Secrets Act of 2016 (DTSA) against OpenAI, its hardware affiliate...

As artificial intelligence tools become integral to legal practice, they introduce unprecedented vulnerabilities to attorney-client privilege and confidentiality protections. Recent U.S. court decisions reveal conflicting interpretations of whether documents generated using public AI platforms retain privileged status, raising critical questions about data retention policies, third-party disclosure, and the fundamental nature of confidential legal communications in the digital age.

Although a refined description may not be in hand when the complaint is filed, it should be prepared without delay so as to be available when the need to specify the substance of the trade secrets arises.

Understanding the fundamental differences between patents, trademarks, and copyrights is crucial for anyone looking to protect their intellectual property. This comprehensive guide explores how each form of protection works, when to use them, and debunks common misconceptions that could leave your creative works, inventions, or brand vulnerable.

Section 409A of the Internal Revenue Code (Section 409A) imposes strict rules governing the timing of deferred compensation payments, such as when and under what circumstances such payments can be made.

The landscape of tariff enforcement is intensifying, creating significant compliance, financial, and operational challenges for importers.

When Zaha Hadid Architects rebranded as ZHA following a protracted legal battle with the Zaha Hadid Foundation over trademark licensing fees, it raised fundamental questions about founder succession planning in professional services firms. This article examines whether the choice between perpetual royalties and complete separation was truly the only path, proposing an innovative Equity-for-Legacy Model that could have preserved both commercial sustainability and cultural legacy through aligned ownership rat

Teva Pharmaceuticals and Polpharma Biologics have entered into a global licensing agreement for the commercialization of a biosimilar candidate to Genentech's OCREVUS (ocrelizumab), a treatment for multiple sclerosis. The agreement combines Polpharma Biologics' development expertise with Teva's commercial capabilities across major markets including the United States, Europe, and several other territories. Under the terms, Polpharma Biologics will handle development and manufacturing while Teva manages regul

When a non-U.S. company obtains a U.S. trademark registration based on a foreign registration without U.S. use, failing to file the required Declaration of Use within six years can result in cancellation with serious consequences. A recent TTAB decision demonstrates how a lapsed registration loses all protective value, even against later-filed confusingly similar marks that were registered while the original registration was still active.

Understanding the fundamental differences between patents, trademarks, and copyrights is crucial for anyone looking to protect their intellectual property. This comprehensive guide explores how each form of protection works, when to use them, and debunks common misconceptions that could leave your creative works, inventions, or brand vulnerable.

Connect with Foley & Lardner LLP's intellectual property and litigation professionals, including Vanessa Miller, Ann-Marie Uetz, and Nicholas Ellis. Access their direct contact information and expertise in IP law and legal representation.

Earlier this year, the UK Supreme Court gave its judgment in Emotional Perception AI Limited v Comptroller General of Patents, Designs and Trade Marks.